Thanks for emailing that article!
“Glaucoma Research Foundation gives me hope that I will be able to keep my vision.”
Christopher Wilmoth, a young glaucoma patient, said these words as he addressed more than 320 guests and introduced the auctioneer at the Glaucoma 360 Annual Gala on January 28, 2016.
Thanks to generous support from our donors and industry sponsors close to $800,000 was raised from Glaucoma 360 to help fulfill Christopher’s wish to “find a cure so I don’t end up going blind.”
As a result, the live auction’s Fund-A-Scientist raised more than $200,000 as part of a matching challenge initiated by June Behrendt Otto of the Edward Joseph Daly Foundation, Sharma and Paul Schacknow, MD, PhD, of the Schacknow Family Foundation, and Elizabeth and James B. Wise, MD. In addition to Gala attendees, online donors also participated in the match and helped to reach this historic goal to fund innovative glaucoma research programs.
During the evening, the Catalyst Award was presented to Charlot and Dennis Singleton for their extraordinary leadership and philanthropic contributions to medicine and education.
James B. Wise, MD received the Visionary Award in recognition of his remarkable career in ophthalmology including the development of argon laser trabeculoplasty or ALT, for the treatment of open-angle glaucoma.
The President’s Award was presented to Masashi Oka, Executive Chairman, emeritus of MUFG Union Bank to honor him for his help in generating support to forward our mission and in recognition of his outstanding community involvement.
Stuart McKinnon, MD, PhD received the 2016 Shaffer Prize for his notable research project funded from the Shaffer Grants for Innovative Research.
Co-chaired by Nobuko Saito Cleary and Gary Cleary, PharmD, PhD, the Annual Gala included the Innovators Circle reception hosted by Mona Zander, a silent and live auction, and fabulous entertainment provided by award winning soprano Julie Adams, a San Francisco Opera Adler Fellow and acclaimed pianist John Churchwell, PhD.
The Annual Gala kicked off the 5th Annual Glaucoma 360 which includes the New Horizons Forum and a continuing medical education symposium for ophthalmologists. Since its establishment in 2012, more than 55 companies have presented their new developments and innovations in glaucoma drug delivery, pharmaceuticals and devices with the goal of moving new ideas forward to help patients preserve their vision.
In his summation at the Forum, Robert D. Fechtner, MD, Director of Glaucoma and Professor of Ophthalmology at Rutgers University, highlighted the importance of this unique gathering: “For one day, all the stakeholders are together to talk about how are we are going to move glaucoma treatment forward and how we are going to have a world without blindness from glaucoma. It is a brave new world, and we are advancing toward a New Horizon for patients.”
Please mark your calendar for next year’s Glaucoma 360 from February 2 to 4, 2017 in San Francisco.
Last reviewed on October 29, 2017
This article appeared in the May 2016 issue of Gleams.Subscribe